Target intelligence / Profile preview

Collagen alpha-6(VI) chain (COL6A6)

Target
COL6A6
Molecular classification
Extracellular matrix protein, Collagen family member (type VI collagen), Other (not a receptor, enzyme, transporter, etc.)
01

Overview

Collagen alpha-6(VI) chain is a large extracellular matrix glycoprotein encoded by the COL6A6 gene, featuring multiple von Willebrand factor type A domains and a characteristic triple-helical region. It belongs to the expanded collagen VI family, which comprises six genetically distinct alpha chains (α1 to α6), and participates in the structural organization of connective tissues such as skin, muscle, cartilage, bone, and cornea. COL6A6 may display tissue-restricted expression, with particular abundance in regions of the skin and neuromuscular junction. While the fundamental role of collagen VI is mechanical stabilization of the extracellular matrix and cell anchorage, recent studies suggest possible involvement of COL6A6 in skin homeostasis and pathology (e.g., atopic dermatitis). However, COL6A6 is not currently classified as a receptor, enzyme, or classic therapeutic target. Its molecular assembly and structure resemble those of collagen alpha-3(VI) chain, suggesting possible evolutionary and functional parallels. If more specific disease associations or therapeutic roles for COL6A6 emerge, these entries may be updated accordingly.

Other names
Collagen alpha-6(VI) chainCOL6A6collagen, type VI, alpha 6collagen type VI alpha 6 chain
02

Biological functions

Structural component of extracellular matrixTissue homeostasisPotential roles in cell adhesion and interaction (via its von Willebrand factor domains)
03

Disease associations

Skin diseases (elevated COL6A6 fragments in atopic dermatitis)The broader collagen VI family is implicated in congenital muscular dystrophy and tissue fibrosis, but specific disease associations for COL6A6 remain limitedOther (potential involvement in ECM-related pathologies)
04

Biomarkers

Elevation of COL6A6 fragments in serum may reflect skin pathology (e.g., in atopic dermatitis)Other collagen VI chains (especially α3) serve as biomarkers in systemic sclerosis, but COL6A6-specific use is limited

Beyond the preview

Go deeper on Collagen alpha-6(VI) chain (COL6A6).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Collagen alpha-6(VI) chain (COL6A6).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call